Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
Clinical trial NCT03486938 · COMPLETED
Trial details
- NCT number
- NCT03486938
- Sponsor
- AgeneBio
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2022-11-02
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.